CheckMyRecalls

BioSpectra, Inc. recalls Biospectra Tris/Tromethamine

Published
14 Oct 2026
Units affected
200 kg
Agency
FDA
Country
United States

The hazard

Failed stability specifications

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25

Brand / company
BioSpectra, Inc.
Codes / lots
Lot#: TRIS -E04-0226-0016; Exp 2/29/28
Distribution
CA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 14 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.